Literature DB >> 6229074

Analysis of cloned T cell function. II. Differential blockade of various cloned T cell functions by cyclosporine.

C G Orosz, D C Roopenian, M B Widmer, F H Bach.   

Abstract

Cyclosporine has profound suppressive effects on selected in vitro functions of cloned T lymphocytes. Cyclosporine inhibits the antigen-induced proliferation of the helper T cell clone 12-11. The effective dose required to reduce this response by 50% (ED50) is 28 ng/ml. In contrast, the proliferation of clone 12-11 induced by exogenous growth factors in secondary mixed lymphocyte culture supernatant (2 degrees MLC SN), is relatively insensitive to cyclosporine (ED50 = 4600 ng/ml). Furthermore, cyclosporine abrogates both antigen-induced and mitogen-induced secretion of lymphokines by clone 12-11, indicating that cloned helper T cell function is sensitive to cyclosporine even when interactions between specific alloantigens and their cell surface receptors are bypassed with mitogen. The suppressive effect of cyclosporine is not limited to helper T cell clones. The cytolytic T lymphocyte (CTL) clone 5MD2-2 is also sensitive to cyclosporine. Again, cyclosporine (100 ng/ml) blocks the antigen-driven, but not the exogenous lymphokine-driven, component of clone 5MD2-2 proliferation. This suppression does not result from the occlusion of antigen receptors or from antigen deformation by cyclosporine, because clone 5MD2-2 remains capable of antigen-specific cytolysis in the presence of cyclosporine concentrations that can suppress its proliferation. Finally, the ability of clone 5MD2-2 to remove IL-2 activity from culture media, a function that is significantly enhanced by contact with specific alloantigen, is not influenced by suppressive cyclosporine concentrations.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6229074     DOI: 10.1097/00007890-198336060-00024

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  12 in total

1.  Treatment of aplastic anemia with cyclosporin A, methylprednisolone, and antithymocyte globulin.

Authors:  N Frickhofen; W Heit; A Raghavachar; F Porzsolt; H Heimpel
Journal:  Klin Wochenschr       Date:  1986-11-17

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Combination therapy of cyclosporine with steroid inhibits gamma-interferon and interleukin-1 gene expression at the level of mRNA synthesis in vivo.

Authors:  N Yoshimura; T Oka; M Kita; H Teraoka; Y Hirai
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

4.  Antigen presentation and HLA-DR expression by FK-506-treated human monocytes.

Authors:  J Woo; D J Propper; A W Thomson
Journal:  Immunology       Date:  1990-12       Impact factor: 7.397

Review 5.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

6.  Interleukin-2 receptor gene expression in kidney transplant recipients treated with cyclosporin A.

Authors:  N Yoshimura; T Oka; T Amagai; Y Horii; J Imanishi
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

7.  Differential regulation of colony-stimulating factors and interleukin 2 production by cyclosporin A.

Authors:  M Bickel; H Tsuda; P Amstad; V Evequoz; S E Mergenhagen; S M Wahl; D H Pluznik
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

8.  Cyclosporin A augments angiotensin II-stimulated rise in intracellular free calcium in vascular smooth muscle cells.

Authors:  J Pfeilschifter; U T Rüegg
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

9.  Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription.

Authors:  M Krönke; W J Leonard; J M Depper; S K Arya; F Wong-Staal; R C Gallo; T A Waldmann; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

10.  Cyclosporin A and prednisolone do not inhibit the expression of high-affinity receptors for interleukin 2.

Authors:  E Bloemena; M H Van Oers; S Weinreich; P T Schellekens
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.